News

A recent webinar from BD shared important insights into patient fear and anxiety over self-injection and how the right device ...
Explore the innovative subcutaneous delivery of isatuximab for multiple myeloma, enhancing patient experience and treatment ...
The researchers conclude that the RDD equipped with a ½-inch 14-gauge needle is adequate for subcutaneous injections with least amount of muscle penetration and equal to that of a hand syringe ...
ASCO: new Sarclisa data support subcutaneous administration with on-body injector New data from two clinical studies demonstrated that Sarclisa administered subcutaneously via an investigational ...
Figure 1. Structure of the Fu’s subcutaneous needling needle. (A) ① Fu’s subcutaneous needling. ② Protective cover. ③ Soft tube. ④ Built-in rivets. ⑤ Buckle upwards. ⑥ Point-like bulge. ⑦ Stainless ...
While holding the needle like a dart, slide it into the skin at a 90-degree angle: Needles for subcutaneous injections are usually short and small and should go all the way into the skin.
Intravenous (IV): when a needle is inserted into a vein to administer fluids or medications directly into the bloodstream. Overall response rate: how many patients experienced a significant shrinkage ...
Therapeutic monoclonal antibody (mAb) drug products are increasingly used to treat both chronic and acute diseases. These mAb drug products are often developed for subcutaneous (SC) injection to ...
The recommended dosing for subcutaneous nivolumab varies by indication: 600 mg of nivolumab with 10,000 units of hyaluronidase every 2 weeks, 900 mg of nivolumab with 15,000 units of hyaluronidase ...
For men weighing more than 260 lbs. and women weighing more than 200 lbs., a longer 1.5-inch-length needle with the same 22 to 25-gauge needle should be used.
Subcutaneous injections deliver medication into the fat layer just beneath the skin, commonly used for insulin, hormones, or vaccines with a small needle.
The Food and Drug Administration (FDA) approved Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs), a subcutaneous injection, for all previously approved indications of the intravenous ...